Award

FIS PI22/00647

Funder: Instituto de Salud Carlos III

Funded outputs count: 6

Funder award ID: FIS PI22/00647

OpenAlex ID: G3665640868

Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited

2025 · Luis Gerardo Rodríguez-Lobato, Oriol Cardús, et al. · Cancer Immunology Research · 4

Attrition rates and treatment outcomes in multiple myeloma: real-world data over a 40-year period

2025 · Luis Gerardo Rodríguez-Lobato, Anna de Daniel, et al. · Blood Cancer Journal · 11

PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma

2024 · Laura Martinez-Verbo, Yoana Veselinova, et al. · Leukemia · 7

The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma

2024 · Anna de Daniel, Luis Gerardo Rodríguez‐Lobato, et al. · HemaSphere · 14

Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution

2023 · Luis Gerardo Rodríguez-Lobato, Natalia Tovar, et al. · Cancers · 3

Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature review

2023 · Javier Nogués-Castell, Silvia Feu-Basilio, et al. · Frontiers in Oncology · 1